About
Platform
Pipeline
Partners
Careers
News
NEWS
NEW FRONTIERS IN CANCER TREATMENT
ASGCT Poster Presentation: “Systematic identification of potent guide RNAs with minimal off-target activity for the CRISPR/Cas9 engineering of KSQ-001, and engineered Tumor Infiltrating Lymphocyte (eTIL™)”
Click to download PDF file.
Previous
View All Press Releases
Next